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606Objective: The goal of this study was to examine the effect of clinical depression, posttraumatic stress disorder,
and comorbid depression and posttraumatic stress disorder on in-hospital mortality after a coronary artery bypass
grafting surgery. It is hypothesized that depression, posttraumatic stress disorder, and comorbid depression and
posttraumatic stress disorder will independently contribute to an increased risk for in-hospital mortality rates after
coronary artery bypass grafting surgery.
Methods:We performed a retrospective analysis of the 2006 Nationwide Inpatient Sample database. The Nation-
wide Inpatient Sample database provides information on approximately 8 million US inpatient stays from about
1000 hospitals. We performed c2 and unpaired t tests to evaluate potential confounding group demographic and
medical variables. Hierarchic logistic regression was used with forced order entry of depression, posttraumatic
stress disorder, and comorbid depression and posttraumatic stress disorder.
Results: Deceased patients were more likely to have had depression (alive, 24.8%; deceased, 60.3%; P<.001),
posttraumatic stress disorder (alive, 13.4%; deceased, 56.1%; P<.001), and cormorbid depression and posttrau-
matic stress disorder (alive, 7.8%; deceased, 48.5%; P<.001). After adjusting for potential confounding factors,
patients with depression (odds ratio, 1.24; 95% confidence interval, 1.02–1.50), posttraumatic stress disorder
(odds ratio, 2.09; 95% confidence interval, 1.65–2.64), and comorbid depression and posttraumatic stress disor-
der (odds ratio, 4.66; 95% confidence interval, 3.46–6.26) had an increased likelihood of in-hospital mortality
compared with that seen in patients who were alive.
Conclusions: Two findings were noteworthy. First, depression, posttraumatic stress disorder, and comorbid
depression and posttraumatic stress disorder are prevalent in patients undergoing coronary artery bypass grafting
procedures. Second, depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress
disorder increase the risk of death by magnitudes comparable with well-established physical health risk factors
after coronary artery bypass grafting surgery. The implications for clinical practice and future directions are
discussed. (J Thorac Cardiovasc Surg 2010;140:606-10)Coronary artery disease (CAD) remains the leading cause of
death in the United States, with more than 650,000 deaths
registered in 2005.1 Patients with severe narrowing or block-
age of the left main coronary artery or those with disease in-
volving 3 coronary arteries are generally considered for
coronary artery bypass grafting (CABG) surgery. Research
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The Journal of Thoracic and Cardiovascular Surgstay, recurrent cardiac events, and in-hospital mortality, after
a CABG surgery cannot be fully explained by traditional risk
factors alone, such as age, sex, and medical comorbidities
(eg, diabetes).2,3 As a result, the role of psychologic risk fac-
tors in explaining such outcomes has recently emerged.
To date, multiple longitudinal and cross-sectional studies
have examined the association between negative CAD-re-
lated events and psychologic functioning, including depres-
sion.4 For example, preoperative depressive symptoms have
been associated with cardiac readmissions up to 6 months2
and with higher rates of cardiac events between 1 and 8
years.3 Depressive symptoms also significantly predict mor-
tality 2 to 5 years after CABG surgery, independent of med-
ical and operative factors.3,5,6 Much of the research
investigating the role of psychologic factors in explaining
outcomes after a CABG surgery has focused on preoperative
depression. In contrast to depression, the influence of other
psychologic conditions, such as posttraumatic stress disor-
der (PTSD), on outcomes after CABG surgery has received
less research attention.4ery c September 2010
Abbreviations and Acronyms
ANS ¼ autonomic nervous system
CABG ¼ coronary artery bypass grafting
CAD ¼ coronary artery disease
HRV ¼ heart rate variability
ICD-9-CM ¼ International Classification of Dis-
eases, 9th Revision, Clinical Modi-
fication
NIS ¼ Nationwide Inpatient Sample
OR ¼ odds ratio
PTSD ¼ posttraumatic stress disorder
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outcome linkage creates a large gap in the literature for 2 rea-
sons. First, pathophysiologic studies have associated both
depression and PTSD with increased secretion of corticotro-
pin-releasing factor. However, the increased secretion is as-
sociated with hypocortisolemia in patients with PTSD,
whereas severe depression is associated with hypercortisole-
mia, which suggests that the pathophysiology of the 2 disor-
ders might be distinct.7 Second, psychiatric comorbidities
can act synergistically, potentially affecting cardiac progno-
sis adversely. The clinical implications of assessing for and
treating only depression to the exclusion of PTSD might
negatively affect cardiac outcomes.
The goal of this study was to examine the effect of clinical
depression, PTSD, and comorbid depression and PTSD on
mortality after a CABG surgery. It is hypothesized that de-
pression, PTSD, and comorbid depression and PTSD will
independently contribute to an increased risk for in-hospital
mortality rates after a CABG surgery. Furthermore, given
that both these disorders are linked to autonomic nervous
system (ANS) dysregulation, it is hypothesized that comor-
bid depression and PTSD will have the greatest effect on
mortality rates. If these hypotheses are supported, the case
for ANS dysregulation as a potential mechanism responsible
for the observed increase in mortality after a CABG surgery
will be strengthened.MATERIALS AND METHODS
Patient Population
Institutional reviewboard approval was obtained from the hospital facility,
as well as from the authors’ University Human Subject’s Committee. TheNa-
tionwide Inpatient Sample (NIS) 2006 database was used to identify patients
for this study. The NIS is a part of the Healthcare Cost and Utilization Project
and contains about 8million hospital discharges sampled from1000 hospitals.
The 2006 NIS database provides demographic, medical, and psychologic dis-
ease severity measures; postoperative complications; discharge disposition;
and procedure and diagnostic codes classified according to the International
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM).8
By using the 2006 NIS database, 62,665 discharge records of patients
who underwent primary CABG were identified. Independent variables in
this study included age; sex (ie, female ¼ 1 and male ¼ 0); race (ie, whiteThe Journal of Thoracic and Ca¼ 1 and other ¼ 0); median household income based on patient’s ZIP code
($1–$44,900 ¼ 1 and $45,000 ¼ 0); the Deyo, Cherkin, & Ciol Comor-
bidity Index9; a depressive disorder diagnosis (ie, depression ¼ 1 and no
depression ¼ 0); a PTSD diagnosis (ie, PTSD ¼ 1 and no PTSD ¼ 0);
and a diagnosis of comorbid depression and PTSD (depression and PTSD
¼ 1 and no depression and PTSD¼ 0). The Deyo, Cherkin, & Ciol Comor-
bidity Index, which is adapted from the Charlson Comorbidity Index,10 is
designed to capture comorbid conditions recorded in the inpatient setting us-
ing ICD-9-CM diagnosis and procedure codes. The Deyo, Cherkin, & Ciol
Comorbidity Index has been widely used in outcomes studies with admin-
istrative datasets as the principal data source.11 It assesses comorbidmedical
conditions, such as myocardial infarction, congestive heart failure,
peripheral vascular disease, cerebrovascular disease, dementia, chronic
obstructive pulmonary disease, rheumatologic disease, mild liver disease,
diabetes, diabetes with complications, hemiplegia or paraplegia, renal dis-
ease, malignancy, moderate-to-severe liver disease, metastatic solid tumors,
and AIDS/HIV. The outcome variable in this study was in-hospital mortal-
ity. Because the NIS database contains only inpatient data, deaths occurring
after hospital discharge were excluded from analyses.
Data Analysis
Data analyses proceeded in 2 sequential steps. First, c2 and unpaired
t tests were performed to evaluate potential confounding group demo-
graphic and medical variables between the alive and deceased groups.
Any variable that differed significantly between the 2 groups was used in
subsequent regression models to test that variable’s independent influence
on medical outcomes after CABG surgery. Hierarchic logistic regression
was used with forced order entry of depression, PTSD, and comorbid de-
pression and PTSD. For the analyses, there were 3 data entry blocks in
the hierarchy. Variables that have been shown in the literature to be associ-
ated with negative outcomes after CABG surgery were entered in the first
block as potential confounding variables. In the second block these potential
confounding variables and depression and PTSD were evaluated simulta-
neously. In the third block these variables were entered in with comorbid
depression and PTSD. We decided to use dummy variable coding for co-
morbid depression and PTSD as opposed to an interaction term for ease
of interpretation. It should be noted that entering comorbid depression
and PTSD in the third block is similar to creating an interaction term. The
results are identical to each other with respect to odds ratios (ORs).RESULTS
Table 1 provides the demographic and clinical data for the
aggregate and group-specific samples. The aggregate sample
(n ¼ 62,665) consisted mostly of white (85.3%) male
(71.3%) subjects with a mean age of 66.0 years (standard de-
viation, 10.87years). Comorbid conditions ranged from0.0%
to 34.2% for AIDS/HIV and myocardial infarction, respec-
tively. Of the sample, 25.9% had a diagnosis of depression,
14.7% had a diagnosis of PTSD, and 9.0% had a diagnosis
of comorbid depression and PTSD. As indicated in Table 1,
the alive and deceased groups differed significantly in terms
of age; sex; race; median household income based on ZIP
code; Deyo, Cherkin, & Ciol Comorbidity Index; depression;
PTSD; and comorbid depression and PTSD. Therefore these
variables were included in subsequent regression models.
Table 2 contains results of hierarchic logistic regression
analysis assessing the influence of depression, PTSD, and
comorbid depression and PTSD on in-hospital mortality
among patients undergoing CABG surgery. Block 1rdiovascular Surgery c Volume 140, Number 3 607
TABLE 1. Demographic and clinical data
Demographics Total (n ¼ 62,656) Alive (n ¼ 60,825) Deceased (n ¼ 1831) P value
Age (y) 66.0 (10.87) 65.8 (10.86) 70.64 (10.57) <.001
Male sex 44,672 (71.3%) 43,534 (71.6%) 1133 (61.9%) <.001
White race 37,561 (85.3%) 36,433 (85.3%) 1125 (83.2%) .031
Median household income based on ZIP code <.001
$1–$35,900 28,569 (45.6%) 27,615 (45.4%) 954 (52.1%)
$45,000 34,087 (54.4%) 33,210 (54.6%) 877 (47.9%)
Deyo, Cherkin, & Ciol Comorbidity Index 1.34 (1.14) 1.32 (1.13) 1.72 (1.22) <.001
Myocardial infarction 21,445 (34.2%) 20,600 (33.9%) 844 (46.1%) <.001
Congestive heart failure 13,907 (22.2%) 13,084 (21.5%) 820 (44.8%) <.001
Peripheral vascular disease 4617 (7.4%) 4486 (7.4%) 130 (7.1%) .657
Cerebrovascular disease 4177 (6.7%) 3984 (6.5%) 192 (10.5%) <.001
Dementia 44 (0.1%) 43 (0.1%) 1 (0.1%) .798
COPD 12,013 (19.2%) 11,572 (19.0%) 438 (23.9%) <.001
Rheumatologic disease 814 (1.3%) 794 (1.3%) 20 (1.1%) .428
Peptic ulcer disease 544 (0.9%) 523 (0.9%) 21 (1.1%) <.001
Mild liver disease 200 (0.3%) 191 (0.3%) 9 (0.5%) .185
Diabetes 18,938 (30.2%) 18,550 (30.5%) 387 (21.1%) <.001
Diabetes with chronic complications 2518 (4.0%) 2438 (4.0%) 78 (4.3%) .589
Hemiplegia or paraplegia 189 (0.3%) 174 (0.3%) 15 (0.8%) <.001
Renal disease 51 (0.1%) 48 (0.1%) 3 (0.2%) .209
Malignancy 837 (1.3%) 798 (1.3%) 39 (2.1%) .003
Moderate or severe liver disease 43 (0.1%) 38 (0.1%) 5 (0.3%) .001
Metastatic solid tumor 59 (0.1%) 55 (0.1%) 4 (0.2%) .078
AIDS/HIV 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Depression 16,215 (25.9%) 15,107 (24.8%) 1104 (60.3%) <.001
PTSD 9202 (14.7%) 8170 (13.4%) 1027 (56.1%) <.001
Comorbid depression and PTSD 5626 (9.0%) 4734 (7.8%) 888 (48.5%) <.001
COPD, Chronic obstructive pulmonary disease; PTSD, posttraumatic stress disorder.
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morbidity Index contributed to the prediction of group mem-
bership (c2 [4, 44,046] ¼ 432.6, P<.001). The Nagelkerke
R2 value, a comparable statistic to the R2 value in linear re-
gression, was 0.041. The Hosmer–Lemeshow test, a test of
the model’s goodness of fit, produced a fail-to-reject deci-
sion (c2 [8, 44,046] ¼ 8.45, P ¼ .391), a result consistentTABLE 2. Hierarchic logistic regression analyses assessing depression
and PTSD in predicting mortality in patients after CABG surgery
Variable B SE B Odds ratio (95% CI)
Constant 6.324 0.212 
Age 0.029y 0.003 1.023 (1.023–1.035)
Gender 0.123* 0.060 1.131 (1.005–1.274)
Race 0.049 0.078 0.953 (0.817–1.111)
Median household income 0.212* 0.079 1.122 (0.966–1.322)
Deyo, Cherkin, & Ciol
Comorbidity Index
0.104y 0.023 1.110 (1.060–1.162)
Depression 0.215* 0.098 1.240 (1.023–1.502)
PTSD 0.736y 0.120 2.088 (1.651–2.640)
Comorbid depression and PTSD 1.539* 0.151 4.658 (3.466–6.261)
Note: Nagelkerke R2 ¼ 0.041 for block 1 (Ps<.001); change Nagelkerke R2¼ 0.123
for block 2 (Ps<.001); change Nagelkerke R2¼ 0.011 for block 3 (Ps<.001). PTSD,
Posttraumatic stress disorder; CABG, coronary artery bypass grafting; SE, standard er-
ror; CI, confidence interval. *P< .05. yP< .001.
608 The Journal of Thoracic and Cardiovascular Surgwith the assumption that the specified logistic model was
correct. Independent significant predictors of mortality in-
cluded age (OR, 1.05), sex (OR, 1.31), race (OR, 0.815),
household income based on ZIP code (OR, 1.12), and the
Deyo, Cherkin, & Ciol Comorbidity Index (OR, 1.26). In
block 2 depression and PTSDwere entered and added signif-
icantly to the model with a change in c2 value (c2 [2, 44,046]
¼ 1332.4, P< .001). The change in Nagelkerke R2 value
was 0.123. Independent significant predictors of mortality
included age (OR, 1.027); Deyo, Cherkin, & Ciol Comor-
bidity Index (OR, 1.08); depression (OR, 2.51); and PTSD
(OR, 5.34). In block 3 comorbid depression and PTSD
was entered and added significantly to the model with
a change in c2 value (c2 [1, n ¼ 44,046] ¼ 119.8,
P< .001). The change in Nagelkerke R2 value was 0.011.
Independent significant predictors of mortality included
age (OR, 1.03); sex (OR, 1.13); Deyo, Cherkin, & Ciol Co-
morbidity Index (OR, 1.11); depression (OR, 1.24); PTSD
(OR, 2.08); and comorbid depression and PTSD (OR, 4.66).DISCUSSION
There has been little systematic effort to investigate the
role of other psychologic factors, such as PTSD, in explain-
ing outcomes after CABG surgery. To our knowledge, thereery c September 2010
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comorbidity of depression and PTSD on mortality after
a CABG outcome. This study found that depression,
PTSD, and comorbid depression and PTSD independently
and collectively contributed to increased in-hospital mortal-
ity. Initial analyses comparing deceased and alive patients
revealed significant differences between groups in age,
sex, race, depression, PTSD, and comorbid depression and
PTSD diagnoses. The 2 groups were similar on preoperative
medical comorbidities, as measured with the Deyo, Cherkin,
& Ciol Comorbidity Index. Deceased patients were more
likely to be older, female, and nonwhite and to have depres-
sion, PTSD, or comorbid depression and PTSD diagnoses.
These findings are preliminary, and further investigation is
warranted.
Hierarchic logistic regression analyses indicated that age;
sex; race; having a lower median household income based
on ZIP code; Deyo, Cherkin, & Ciol Comorbidity Index; de-
pression; PTSD; and comorbid depression and PTSD were
significant predictors of mortality. An examination of the
Nagelkerke R2 value change and the ORs suggests that de-
pression, PTSD, and comorbid depression and PTSD in-
crease the risk of death by magnitudes comparable with
well-established physical health risk factors (eg, age) after
CABG surgery. Older patients carried an increased risk for
in-hospital mortality. A recent review of adverse events in
CABG trials reported that the ORs associated with in-hospi-
tal mortality after CABG operations was 1.65.12 In this study
the ORs found for age were similar to those reported by
others.12 This finding establishes PTSD as an independent
predictor of in-hospital mortality. Furthermore, depres-
sion–PTSD comorbidity was the strongest predictor, with
the odds of mortality being 4 times higher in patients with
both diagnoses than in those who did not have comorbid de-
pression and PTSD.
Despite their unique presentations, one factor that has
been understudied but appears to be central to the manifes-
tation of both depression and PTSD is the role of the
ANS. Three lines of evidence suggest that altered ANS ac-
tivity in patients with depression and PTSD might account
for the documented increased risk of mortality in patients
with CAD.
First, both patients with depression and those with PTSD
have been shown to have increased levels of plasma and uri-
nary catecholamines (primarily norepinephrine) compared
with levels seen in control subjects.13,14 This finding is par-
ticularly noteworthy given that plasma norepinephrine con-
centrations generally parallel the level of activity of the
sympathetic nervous system and are highly correlated with
sympathetic neural activity.14
Second, resting heart rate is higher in patients with depres-
sion and PTSD compared with that seen in control sub-
jects.15,16 Both psychiatric conditions are also associated
with an exaggerated heart rate response to physical andThe Journal of Thoracic and Capsychologic stressors in comparison with that seen in med-
ically well patients12 and patients with CAD.17,18 Given
that one of the primary functions of the ANS is to regulate
heart rate through a reciprocal interaction of the sympathetic
and parasympathetic nervous systems, the increased heart
rate suggests altered ANS function.
A third line of evidence is based on previous studies that
report decreased heart rate variability (HRV) among de-
pressed patients compared with that seen among nonde-
pressed patients.14 Over the last 2 decades, HRV has
emerged as an important marker for examining autonomic
flexibility, the continuous interplay between the parasympa-
thetic and sympathetic influences, on heart rate.19 Increased
HRV has been used as a marker of increased vagal activity
and has been consistently associated with greater capacities
to regulate stress, emotional arousal, and attention,20
whereas low HRV has been associated with excessive car-
diac sympathetic modulation, inadequate parasympathetic
modulation, or both.19 A number of studies have found
HRV to be lower in both patients with depression and those
with PTSD compared with that seen in control subjects.21
These findings strengthen the case for ANS dysregulation
as a potential causal mechanism for increased mortality after
CABG surgery.
Future studies should examine the effect of established
ANS dysregulation markers in the presence of the diagnosis
to examine the variance accounted for by the psychologic and
physiopathologic variables. If ANS dysregulation accounts
for the relation between emergent psychologic factors and
medical outcomes, the implications for the preoperative
assessment and treatment of both ANS dysregulation and
psychologic comorbidities might be extensive.
The results of this study have implications for early assess-
ment and integrated trauma-informed treatment of psychiat-
ric conditions. Because comorbid psychiatric conditions,
such as depression, are more frequently observed in cardiac
care settings,22 clinicians (eg, cardiologists, nurses, and car-
diothoracic surgeons) should accurately assess for comorbid
psychiatric conditions, such as depression and PTSD,
through the application of mental health screening instru-
ments. Furthermore, given the challenges of cardiovascular
care and the importance of early treatment for psychiatric
conditions, patients with cardiac disease and comorbid de-
pression or PTSD will benefit from the application of brief,
evidence-based interventions for treating depression and
PTSD.
As with many studies that use large administrative data-
bases, there are several limitations to consider, the first of
which involves the psychiatric diagnosis of patients. Our
findings are based on the ICD-9-CM diagnosis codes se-
lected for conditions associated with CABG, depression,
andPTSD.Selected diagnosis codesmight not capture all rel-
evant cases and therefore could underestimate the actual
prevalence of these conditions and affect other outcomerdiovascular Surgery c Volume 140, Number 3 609
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cise informationwas not available to validate the diagnosis of
CABG, depression, and PTSD. Thus these findings are pre-
liminary, and further investigation is necessary. However,
based on NIS technical documents, there were a number of
quality control procedures that were used to assess the data
quality for ICD-9-CM diagnoses. The reliability and validity
of numeric data were assessed extensively by using internal
and external forms of review. For instance, each discharge re-
cord was verified against established norms, when feasible,
and values were compared with related elements. Further-
more, the NIS database was compared with 2 other national
databases (ie, the National Hospital Discharge Survey and
Medical Provider Analysis and Review) to assess for biases
and was found to be quite similar to these 2 databases, partic-
ularly with regard to diagnosis and procedure codes.
Another inherent limitation of using a database is that it
was not possible to establish the proximity of the diagnosis
to the operation or to determine the course or severity of the
diagnosis (eg, reactive vs chronic depression and mild vs se-
vere depression). As one can imagine, a patient with chronic
depression since adolescence is likely different from another
patient with depression caused by a medical condition.
Also, although this study used ICD-9-CM codes to deter-
mine psychiatric diagnoses, patients in both the alive and de-
ceased groups most likely had other comorbid diagnoses that
were not identified; thus some caution is warranted in formu-
lating interpretations pertaining to the true effects of depres-
sion and PTSD onmortality. However, despite the limitation
inherent when using patients with comorbid diagnoses to ex-
amine one particular diagnostic group, this limitation can
also be viewed as addressing the ecologic validity of the
study, given that a large number of patients in the clinical
settings are diagnosed with co-occurring disorders.23 De-
spite these limitations, the current results do provide addi-
tional support for the importance of presurgical screening
for depression and PTSD, as well as the development and
implementation of short-term treatments for depression
and PTSD that might facilitate better outcomes after
CABG operations.
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